Related references
Note: Only part of the references are listed.Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)
B. Castagneto et al.
ANNALS OF ONCOLOGY (2008)
A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer
M. H. Cullen et al.
ANNALS OF ONCOLOGY (2008)
Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group
David Scott Miller et al.
GYNECOLOGIC ONCOLOGY (2008)
Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer
N. S. Horowitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Lymphocyte-predominant and classical Hodgkin's lymphoma:: A comprehensive analysis from the German Hodgkin study group
Lucia Nogova et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancer
August Garin et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non-small-cell lung cancer
Roy S. Herbst et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics
Susan C. Modesitt et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
The therapeutic efficacy of anti-vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice
Qi Li et al.
CLINICAL CANCER RESEARCH (2007)
A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer
Antonio Llombart-Cussac et al.
CLINICAL CANCER RESEARCH (2007)
Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer
Chris H. Takimoto et al.
CLINICAL CANCER RESEARCH (2007)
Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: The Children's Oncology Group
Suman Malempati et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Single-institution experience with pemetrexed and bevacizumab as salvage therapy in advanced non-small-cell lung cancer
Glen J. Weiss et al.
CLINICAL LUNG CANCER (2007)
A phase I study of pernetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer
Tanguy Y. Seiwert et al.
CLINICAL CANCER RESEARCH (2007)
Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: A phase II study of the Gynecologic Oncology Group
Cheryl A. Brewer et al.
GYNECOLOGIC ONCOLOGY (2006)
Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer
Mark A. Socinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B12 in Japanese patients with solid tumours
K. Nakagawa et al.
BRITISH JOURNAL OF CANCER (2006)
Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers:: A Gynecologic Oncology Group study
Maurie Markman et al.
GYNECOLOGIC ONCOLOGY (2006)
Pemetrexed (Alimta®, LY231514) demonstrates clinical activity in chemonaive patients with cervical cancer in a phase II single-agent trial
L. Goedhals et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma
GL Ceresoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer
RG Zinner et al.
CANCER (2005)
The ALPI trial: The Italian/European experience with adjuvant chemotherapy in resectable non-small lung cancer
GV Scagliotti
CLINICAL CANCER RESEARCH (2005)
Phase II evaluation of 9-aminocamptothecin (9-AC, NSC #603071) in platinum-resistant ovarian and primary peritoneal carcinoma: A Gynecologic Oncology Group Study
DS Miller et al.
GYNECOLOGIC ONCOLOGY (2005)
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy
N Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: A gynecologic group study
PM Fracasso et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study
PG Rose et al.
GYNECOLOGIC ONCOLOGY (2003)
Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma
A Hughes et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Phase II trial of pyrazoloacridine in recurrent platinum-resistant ovarian cancer - A Gynecologic Oncology Group study
SC Plaxe et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
Recurrent epithelial ovarian carcinoma: A randomized phase III study of pegylated liposomal doxorubicin versus topotecan
AN Gordon et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: A gynecologic oncology group study
PM Fracasso et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Phase II trial of CI-958 in recurrent platinum-refractory ovarian carcinoma
MA Hoffman et al.
GYNECOLOGIC ONCOLOGY (2000)
Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTA™) and cisplatin:: A multicenter phase II trial
C Manegold et al.
ANNALS OF ONCOLOGY (2000)
Share Paper
